MYC and cancer: We next examined the intracellular levels of lactic acid and ATP to investigate metabolic changes as a consequence of suppression of the c-Myc/PTBP1/PKMs axis operating in the cancer specific energy metabolism and of switching PKM isoforms from PKM2 to PKM1 by each treatment (Figure 5E,F).